Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?
ConclusionThese retrospective data suggest that a dose reduction may be possible for intermediate-risk volumes, especially for the primary site.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Intensity-Modulated Radiation Therapy | Nasopharyngeal Cancer | Radiation Therapy | Study